News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,997 Results
Type
Article (39970)
Company Profile (292)
Press Release (649735)
Section
Business (206411)
Career Advice (2019)
Deals (35675)
Drug Delivery (82)
Drug Development (81522)
Employer Resources (169)
FDA (16078)
Job Trends (15004)
News (348057)
Policy (32717)
Tag
Academia (2559)
Africa (742)
Alliances (49906)
Alzheimer's disease (1160)
Approvals (16005)
Arizona (189)
Artificial intelligence (72)
Asia (37770)
Australia (6268)
Bankruptcy (353)
Best Places to Work (11403)
Biotechnology (216)
C2C Services and Suppliers (79289)
California (1971)
Canada (958)
Cancer (519)
Career advice (1684)
Cell therapy (128)
China (157)
Clinical research (63936)
Collaboration (154)
Colorado (81)
Compensation (86)
Connecticut (79)
COVID-19 (2519)
Cystic fibrosis (73)
Data (343)
Diabetes (84)
Diagnostics (6012)
Drug pricing (65)
Earnings (84184)
Employer resources (144)
Europe (81347)
Events (110786)
Executive appointments (164)
FDA (16332)
Florida (278)
Funding (161)
Gene therapy (95)
GLP-1 (518)
Government (4316)
Healthcare (18716)
Hotbed/Location (486745)
Illinois (284)
Indiana (151)
Infectious disease (2550)
Inflammatory bowel disease (92)
Interviews (310)
IPO (16318)
Job creations (3739)
Job search strategy (1447)
Kansas (98)
Layoffs (399)
Legal (7909)
Lung cancer (114)
Manufacturing (97)
Maryland (412)
Massachusetts (1609)
Medical device (13073)
Medtech (13078)
Mergers & acquisitions (19239)
Metabolic disorders (262)
Michigan (125)
Minnesota (217)
Neuroscience (1317)
New Jersey (608)
New York (618)
NextGen Class of 2024 (6555)
Non-profit (4491)
North Carolina (614)
Northern California (856)
Obesity (159)
Ohio (109)
Opinion (184)
Patents (80)
Pennsylvania (595)
People (56937)
Pharmaceutical (65)
Phase I (19872)
Phase II (28206)
Phase III (20932)
Pipeline (116)
Postmarket research (2557)
Preclinical (8453)
Press Release (71)
Radiopharmaceuticals (231)
Rare diseases (134)
Real estate (6054)
Recruiting (65)
Regulatory (21431)
Research institute (2337)
Resumes & cover letters (352)
South America (1127)
Southern California (791)
Startups (3668)
Texas (254)
United States (8950)
Vaccines (483)
Washington State (259)
Weight loss (135)
Date
Today (133)
Last 7 days (568)
Last 30 days (2572)
Last 365 days (37517)
2024 (26856)
2023 (40436)
2022 (51650)
2021 (56124)
2020 (54499)
2019 (46944)
2018 (35388)
2017 (32546)
2016 (32074)
2015 (38048)
2014 (31839)
2013 (26867)
2012 (29191)
2011 (29867)
2010 (27971)
689,997 Results for "phoenix biotechnology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Phoenix Children’s Research Institute Study Identifies FOXF1 Enhancers Involved in Rare Lung Disease
According to a study published in Nature Communications, research conducted at the Phoenix Children’s Research Institute at the University of Arizona College of Medicine — Phoenix, shows how frequent non-coding FOXF1 gene deletions that interfere with important DNA regulatory regions, called enhancers, can lead to Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACDMPV), a rare, lethal, genetic lung disease which causes respiratory failure in newborns and infants.
June 19, 2024
·
4 min read
Biotech Bay
Phoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business Combination
Phoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms announced that their previously announced business combination has closed, resulting in CERo becoming a publicly-traded company.
February 14, 2024
·
2 min read
BioMidwest
Researchers at Phoenix Children’s First in the World to Produce Mouse Lungs in Rats
Research conducted at the Phoenix Children’s Research Institute at the University of Arizona College of Medicine — Phoenix reports the successful generation of a mouse lung in a rat, according to a paper published in the American Journal of Respiratory and Critical Care Medicine.
March 25, 2024
·
4 min read
BioMidwest
Study from Phoenix Children’s Research Institute Reveals New Way to Prevent Lung Cancer from Spreading
Research conducted at the Phoenix Children’s Research Institute at the University of Arizona College of Medicine — Phoenix shows normalizing cancer tumor vessels and alleviating low oxygen levels in the tumor microenvironment can improve the effectiveness of chemotherapy treatment in lung cancer, according to a paper published in EMBO Molecular Medicine.
April 25, 2024
·
4 min read
Drug Development
Amylyx Pharmaceuticals Announces Topline Results From Global Phase 3 PHOENIX Trial of AMX0035 in ALS
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced topline results from PHOENIX, a global, 48-week, randomized, placebo-controlled Phase 3 clinical trial of AMX0035 (sodium phenylbutyrate and taurursodiol [also known as ursodoxicoltaurine]; RELYVRIO® in the U.S., ALBRIOZA™ in Canada) in people living with amyotrophic lateral sclerosis (ALS).
March 8, 2024
·
15 min read
BioMidwest
Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD
Aclarion, Inc. announced that Nociscan is now available in the greater Phoenix, AZ market at the Barrow Neurological Institute with Dr. Juan Uribe and other area physicians treating chronic low back pain.
January 22, 2024
·
4 min read
Deals
RadNet’s Arizona Diagnostic Radiology Group Joint Venture Acquires Seven Outpatient Imaging Centers in Phoenix, Arizona
RadNet, Inc. announces that its joint ventured Arizona Diagnostic Radiology Group, LLC has acquired seven outpatient imaging centers in Phoenix Arizona from Evernorth Care Group.
January 24, 2024
·
2 min read
Business
UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
UNITY Biotechnology, Inc. reported financial results for the first quarter ended March 31, 2024.
May 14, 2024
·
7 min read
Deals
Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc.
Nika Pharmaceuticals, Inc. (OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.
March 20, 2024
·
2 min read
Pharm Country
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care
BioSig Technologies, Inc. announced that Mayo Clinic-Phoenix has upgraded to the Platform’s subscription model to gain immediate access to the Company’s latest technological advancements in cardiac arrhythmia identification.
November 2, 2023
·
7 min read
1 of 69,000
Next